Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment

NCT01722656 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Submacular Vascularized Pigment Epithelial Detachments

Interventions

DRUG: Aflibercept

Sponsor

Southern California Desert Retina Consultants, MC

Collaborators

[object Object]